Your browser doesn't support javascript.
loading
A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel.
Zhou, Jinhua; Alfraidi, Albandri; Zhang, Shu; Santiago-O'Farrill, Janice M; Yerramreddy Reddy, Venkata Krishna; Alsaadi, Abdulkhaliq; Ahmed, Ahmed A; Yang, Hailing; Liu, Jinsong; Mao, Weiqun; Wang, Yan; Takemori, Hiroshi; Vankayalapati, Hariprasad; Lu, Zhen; Bast, Robert C.
Afiliación
  • Zhou J; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Alfraidi A; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhang S; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Santiago-O'Farrill JM; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yerramreddy Reddy VK; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Alsaadi A; Arrien Pharmaceuticals, Salt Lake City, Utah.
  • Ahmed AA; The Nuffield Department of Obstetrics and Gynecology, University of Oxford, Oxford, United Kingdom.
  • Yang H; The Nuffield Department of Obstetrics and Gynecology, University of Oxford, Oxford, United Kingdom.
  • Liu J; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mao W; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang Y; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Takemori H; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vankayalapati H; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan.
  • Lu Z; Arrien Pharmaceuticals, Salt Lake City, Utah.
  • Bast RC; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 23(8): 1945-1954, 2017 04 15.
Article en En | MEDLINE | ID: mdl-27678456
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteínas Serina-Treonina Quinasas / Antineoplásicos Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteínas Serina-Treonina Quinasas / Antineoplásicos Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article